Eli Lilly Drugs - Search News

Mounjaro enters India as weight-loss drug

Reuters on MSN · 2d

Eli Lilly launches weight-loss drug Mounjaro in India, beats Novo Nordisk to major market

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk for a much-awaited entry into the world's most populous country grappling with increasing rates of obesity and diabetes.

Bloomberg · 3d

Eli Lilly First to Launch Weight Loss Drug in Obesity-Hit India

Eli Lilly and Co. has begun selling its blockbuster weight-loss and diabetes drug Mounjaro in India, pipping rivals in a country that has the world’s third-largest number of obese people.

Markets Insider · 3d

Eli Lilly (LLY) Leads India’s Weight-Loss Drug Race with Mounjaro

Eli Lilly (LLY) has launched its weight-loss and diabetes drug, Mounjaro (tirzepatide), in India, securing a first-mover advantage in a market

18hon MSN

Better Stock to Buy Right Now: Viking Therapeutics vs. Eli Lilly

It's hard to overstate how much demand could be out there for effective weight management drugs. The global anti-obesity drug ...

Eli Lilly’s Dave Ricks takes home $114 million as obesity drugs fuel company’s fortunes

Eli Lilly’s rising fortunes tied to its weight loss and diabetes drugs led to a nine-figure payday for its top executive.

Indianapolis Star on MSN25d

Eli Lilly will build 4 new manufacturing sites to increase domestic drug production

Eli Lilly and Co. is in negotiations with several states and plans to announce the locations of four new manufacturing plants later this year.

3don MSN

5 Reasons It's Not Too Late to Buy Eli Lilly Stock

Eli Lilly (LLY 1.80%) has been around for almost 150 years, finding ways to innovate and grow. Today, it's the most valuable ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results